NattoPharma ASA is announcing that VP for R&D and Regulatory Affairs Anne Bjørnebye Vik has terminated her full time engagement in the company as from September 28th 2009, and has signed a consultancy agreement with the company going forward. Dr. Vik has been instrumental in building up NattoPharma's scientific and regulatory basis for MenaQ7 since early 2006. She has also been responsible for NattoPharma's patent portfolio and QA. As previously announced, her responsibilities are now split between Dr. Leon Schurgers and Dr. Elke Theuwissen in VitaK in Maastricht. NattoPharma wants to thank Dr. Vik for her valuable contribution to development and positioning of the company.

For more information, please contact
Morten Sundstø,
CEO
NattoPharma ASA
Phone no. 0047 950 61 860